>>there will be a big sigh of relief in Irvine when Psychiatric gives the OK for the ADHD trial to start.
True enough. Although it's hard for me to imagine that FDA denies an early Phase 2 trial because Cortex cannot prove something does not exist, it will feel much better if FDA says okay.
In CX717 case, I think Cortex's problem was it can't explain why something exists.
Market Data 
Markets 
AI
